Article Correctness Is Author's Responsibility: FDA Lifts Clinical Hold on Trial for Duchenne Muscular Dystrophy Treatment

The article below may contain offensive and/or incorrect content.

SGT-001 is a novel adeno-associated viral vector mediated gene transfer that could potentially address the underlying genetic cause of DMD, mutations in the dystrophin gene.